Table 2.
Pathway | # DE | p Value |
---|---|---|
Red module | ||
Sphingolipid signaling pathway | 5 | 1.81 × 10−32 |
Glycerophospholipid metabolism | 4 | 0.00016 |
Phospholipase D signaling pathway | 4 | 0.0008 |
Cyclic adenosine monophosphate signaling pathway | 4 | 0.00149 |
Choline metabolism in cancer | 3 | 0.00561 |
Ether lipid metabolism | 2 | 0.01523 |
Glycerolipid metabolism | 2 | 0.03437 |
Green module | ||
Metabolic pathway | 6 | 0.00471 |
Epstein-Barr virus infection | 3 | 0.1168 |
Notch signaling pathway | 2 | 0.1168 |
Pyrimidine metabolism | 2 | 0.1492 |
Basal cell carcinoma | 2 | 0.1492 |
Brown module | ||
Proteoglycans in cancer | 6 | 0.00208 |
Salmonella infection | 4 | 0.00208 |
Terpenoid backbone biosynthesis | 3 | 0.00208 |
Pathways in cancer | 7 | 0.00239 |
Gonadotropin-releasing hormone signaling pathway | 4 | 0.00239 |
Pathway indicates the KEGG pathway being tested; # DE is the number of genes that are differentially expressed in our module; and the false discovery rate is the p value for overrepresentation